Anton Jordi, Montoro María, Loza Estíbaliz, Otón Teresa, Ramirez Susan, Benavent Diego
Department of Paediatric Rheumatology, Hospital Sant Joan de Déu, Barcelona, Spain.
Department of Surgery and Medical-Surgical Specialties, Obstetrics, Gynaecology and Paediatrics, Medicine and Health Sciences School, Universitat de Barcelona, Barcelona, Spain.
Pediatr Rheumatol Online J. 2025 May 1;23(1):45. doi: 10.1186/s12969-025-01094-3.
Nowadays, digital health technologies, including mobile apps, wearable technologies, social media, websites, electronic medical records, and artificial intelligence, are impacting disease management and outcomes. We aimed to analyse the characteristics and use of digital health tools in juvenile idiopathic arthritis (JIA).
We conducted a systematic review (SR) to identify articles examining the characteristics, use, and outcomes (feasibility, usability, and effectiveness) of digital health tools in JIA patients. A sensitive search strategy was performed in Medline, Embase, and Cochrane databases until December 2022 (later updated to March 2024). Two reviewers independently selected the studies and collected the data, including study quality. A descriptive analysis was performed.
A total of 21 studies were included, one SR, six randomised controlled trials, four observational studies, four validation studies, one discovery and verification study, and five qualitative studies. Study quality was generally moderate. Most studies focused on patients with JIA (especially young people), but also on parents and health care professionals. Different digital health technologies were investigated, like websites, mobile apps, wearables, and telemedicine. The main objectives of the tools were self-management, symptom and quality of life monitoring, physical activity tracking, disease knowledge improvement, and medication monitoring. Different themes and contents were usually included in the same digital health tool, such as psychological health, lifestyle, intimacy, or shared decision-making. Tool development and validation processes were poorly or not at all described, and data regarding regulatory compliance, security, or privacy were scarce.
There is significant variability in the type, characteristics, objectives, and contents of digital health tools for JIA. They still show limitations and gaps, thus highlighting the need for better critical assessment and reporting.
如今,数字健康技术,包括移动应用程序、可穿戴技术、社交媒体、网站、电子病历和人工智能,正在影响疾病管理和治疗结果。我们旨在分析青少年特发性关节炎(JIA)中数字健康工具的特点和使用情况。
我们进行了一项系统评价(SR),以识别研究JIA患者数字健康工具的特点、使用情况和结果(可行性、可用性和有效性)的文章。在Medline、Embase和Cochrane数据库中进行了敏感的检索策略,直至2022年12月(后来更新至2024年3月)。两名评审员独立选择研究并收集数据,包括研究质量。进行了描述性分析。
共纳入21项研究,1项系统评价、6项随机对照试验、4项观察性研究,、4项验证性研究、1项发现与验证性研究和5项定性研究。研究质量总体中等。大多数研究关注JIA患者(尤其是年轻人),但也涉及家长和医疗保健专业人员。研究了不同的数字健康技术,如网站、移动应用程序、可穿戴设备和远程医疗。这些工具的主要目标是自我管理、症状和生活质量监测、身体活动追踪、疾病知识改善和药物监测。同一数字健康工具通常包含不同的主题和内容,如心理健康、生活方式、亲密关系或共同决策。工具开发和验证过程描述不佳或根本未描述,关于监管合规性、安全性或隐私的数据很少。
用于JIA的数字健康工具在类型、特点、目标和内容方面存在显著差异。它们仍然存在局限性和差距,因此凸显了进行更好的批判性评估和报告的必要性。